# A Phase 1 Study Assessing Local Cutaneous Effects of SB204

> **NCT02250430** · PHASE1 · COMPLETED · sponsor: **Novan, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** SB204

## Key facts

- **NCT ID:** NCT02250430
- **Lead sponsor:** Novan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02250430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02250430, "A Phase 1 Study Assessing Local Cutaneous Effects of SB204". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02250430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*